BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38314667)

  • 1. Microwave ablation for recurrent primary hyperparathyroidism in four patients with multiple endocrine neoplasia type 1: a case series report.
    Tan J; Zhang Y; Han X; Fan Y; Xu J; Chen G; Liu C; Xu S
    Int J Hyperthermia; 2024; 41(1):2308056. PubMed ID: 38314667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-guided microwave ablation in the treatment of recurrent primary hyperparathyroidism in a patient with MEN1: a case report.
    Liu Z; Zhao Y; Han X; Hu X; Zhang Y; Xu L; Chen G; Liu C; Xu S
    Front Endocrinol (Lausanne); 2023; 14():1175377. PubMed ID: 37795364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism.
    Keutgen XM; Nilubol N; Agarwal S; Welch J; Cochran C; Marx SJ; Weinstein LS; Simonds WF; Kebebew E
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):701-707. PubMed ID: 27464610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review.
    Schreinemakers JM; Pieterman CR; Scholten A; Vriens MR; Valk GD; Rinkes IH
    World J Surg; 2011 Sep; 35(9):1993-2005. PubMed ID: 21713580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence After Surgery for Primary Hyperparathyroidism in 517 Patients With Multiple Endocrine Neoplasia Type 1: An Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines study.
    Santucci N; Ksiazek E; Pattou F; Baud G; Mirallié E; Frey S; Trésallet C; Sébag F; Guérin C; Mathonnet M; Christou N; Donatini G; Brunaud L; Gaujoux S; Ménégaux F; Najah H; Binquet C; Goudet P; Lifante JC
    Ann Surg; 2024 Feb; 279(2):340-345. PubMed ID: 37389888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype.
    Pieterman CR; van Hulsteijn LT; den Heijer M; van der Luijt RB; Bonenkamp JJ; Hermus AR; Borel Rinkes IH; Vriens MR; Valk GD;
    Ann Surg; 2012 Jun; 255(6):1171-8. PubMed ID: 22470073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone and Mineral Metabolism Phenotypes in MEN1-Related and Sporadic Primary Hyperparathyroidism, before and after Parathyroidectomy.
    Marini F; Giusti F; Cioppi F; Maraghelli D; Cavalli T; Tonelli F; Brandi ML
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1.
    Kluijfhout WP; Beninato T; Drake FT; Vriens MR; Gosnell J; Shen WT; Suh I; Liu C; Duh QY
    World J Surg; 2016 Dec; 40(12):2964-2969. PubMed ID: 27402205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of pediatric patients with primary hyperparathyroidism.
    Romero Arenas MA; Morris LF; Rich TA; Cote GJ; Grubbs EG; Waguespack SG; Perrier ND
    J Pediatr Surg; 2014 Apr; 49(4):546-50. PubMed ID: 24726110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single gland excision for MEN1-associated primary hyperparathyroidism.
    Manoharan J; Albers MB; Bollmann C; Maurer E; Mintziras I; Wächter S; Bartsch DK
    Clin Endocrinol (Oxf); 2020 Jan; 92(1):63-70. PubMed ID: 31626728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less Than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.
    Bouriez D; Gronnier C; Haissaguerre M; Tabarin A; Najah H
    World J Surg; 2022 Nov; 46(11):2666-2675. PubMed ID: 35767091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1.
    Singh Ospina N; Thompson GB; Lee RA; Reading CC; Young WF
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E87-90. PubMed ID: 25337928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
    Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
    Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.
    Waldmann J; López CL; Langer P; Rothmund M; Bartsch DK
    Br J Surg; 2010 Oct; 97(10):1528-34. PubMed ID: 20629112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure.
    Nilubol N; Weinstein LS; Simonds WF; Jensen RT; Marx SJ; Kebebew E
    Ann Surg Oncol; 2016 Feb; 23(2):416-23. PubMed ID: 26542588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy.
    Nilubol N; Weisbrod AB; Weinstein LS; Simonds WF; Jensen RT; Phan GQ; Hughes MS; Libutti SK; Marx S; Kebebew E
    World J Surg; 2013 Aug; 37(8):1966-72. PubMed ID: 23722465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidism.
    Choi HR; Choi SH; Choi SM; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY; Lee S; Hong N; Rhee Y
    Sci Rep; 2020 Jun; 10(1):10634. PubMed ID: 32606444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1 Syndrome.
    Libánský P; Čarková J; Kushnir I; Matějková Běhanová M; Procyklová K; Šedý J; Vaculová M; Včelák J; Zikán V; Adámek S
    Physiol Res; 2023 Dec; 72(S4):S423-S427. PubMed ID: 38116778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy.
    Burgess JR; David R; Greenaway TM; Parameswaran V; Shepherd JJ
    Arch Surg; 1999 Oct; 134(10):1119-23. PubMed ID: 10522858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of "Tailored" Parathyroidectomy for Treatment of Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1.
    Horiuchi K; Sakurai M; Haniu K; Nagai E; Tokumitsu H; Yoshida Y; Omi Y; Sakamoto A; Okamoto T
    World J Surg; 2018 Jun; 42(6):1772-1778. PubMed ID: 29138914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.